Adicet Announces Appointment of Katie Peng to the Board of Directors
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced the appointment of Katie Peng to its Board of...
Source: marketscreener.com